Supernus Pharma (SUPN) Tops Q3 EPS by 3c

Supernus Pharma (NASDAQ: SUPN) reported Q3 EPS of $0.39, $0.03 better than the analyst estimate of $0.36. Revenue for the quarter came in at $52.5 million versus the consensus estimate of $43.1 million.

For earnings history and earnings-related data on Supernus Pharma (SUPN) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Worried the AI trade has gone too far? Evercore likes these 4 stocks
• C.H. Robinson acquires DeSpir Logistics for $75 million